Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Cancers
|
April 3, 2021
Multiple Myeloma: Heterogeneous in Every Way
Anaïs Schavgoulidze, Titouan Cazaubiel, Aurore Perrot, et al.
Cancers
|
December 1, 2020
Risk and Response-Adapted Treatment in Multiple Myeloma
Titouan Cazaubiel, Olga Mulas, Lydia Montes, et al.
Journal of Hematology
|
November 23, 2020
Reduce Mortality and Morbidity in Acute Myeloid Leukemia With Hyperleukocytosis With Early Admission in Intensive Care Unit: A Retrospective Analysis
Nathan Mottal, Nahema Issa, Pierre-Yves Dumas, et al.
Ejhaem
|
January 29, 2025
Relapsed Philadelphia chromosome-positive B-cell acute lymphoblastic leukaemia responds well to a combination of modified hyper-CVAD, blinatumomab and tyrosine kinase inhibitor
Gaétan Basile, Jean Galtier, Titouan Cazaubiel, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 4, 2026
Real-World Evidence of Immunotherapy Sequencing in Multiple Myeloma: Durable Responses With BCMA-Targeting Bispecific Antibodies Following Prior GPRC5D-Targeting Therapy
Titouan Cazaubiel, Cyrille Touzeau, Laure Vincent, et al.
British Journal of Haematology
|
May 7, 2022
VANDA regimen followed by blinatumomab leads to favourable outcome in patients with Philadelphia chromosome-negative B-precursor acute lymphoblastic leukaemia in first relapse
Luc Heraudet, Jean Galtier, Simon Favre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 7, 2022
In Multiple Myeloma, High-Risk Secondary Genetic Events Observed at Relapse Are Present From Diagnosis in Tiny, Undetectable Subclonal Populations
Romain Lannes, Mehmet Samur, Aurore Perrot, et al.
Clinical Hematology International
|
September 22, 2025
Improving Advanced-Line Multiple Myeloma Care: Insights and Real-World Challenges from the EMMY Study
Titouan Cazaubiel, Olivier Decaux, Bruno Royer, et al.
Blood
|
April 21, 2024
RAS/RAF landscape in monoclonal plasma cell conditions
Anais Schavgoulidze, Jill Corre, Mehmet Kemal Samur, et al.
Blood
|
February 16, 2022
Primary plasma cell leukemias displaying t(11;14) have specific genomic, transcriptional, and clinical features
Titouan Cazaubiel, Xavier Leleu, Aurore Perrot, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Cancers
|
April 3, 2021
Multiple Myeloma: Heterogeneous in Every Way
Anaïs Schavgoulidze, Titouan Cazaubiel, Aurore Perrot, et al.
Cancers
|
December 1, 2020
Risk and Response-Adapted Treatment in Multiple Myeloma
Titouan Cazaubiel, Olga Mulas, Lydia Montes, et al.
Journal of Hematology
|
November 23, 2020
Reduce Mortality and Morbidity in Acute Myeloid Leukemia With Hyperleukocytosis With Early Admission in Intensive Care Unit: A Retrospective Analysis
Nathan Mottal, Nahema Issa, Pierre-Yves Dumas, et al.
Ejhaem
|
January 29, 2025
Relapsed Philadelphia chromosome-positive B-cell acute lymphoblastic leukaemia responds well to a combination of modified hyper-CVAD, blinatumomab and tyrosine kinase inhibitor
Gaétan Basile, Jean Galtier, Titouan Cazaubiel, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 4, 2026
Real-World Evidence of Immunotherapy Sequencing in Multiple Myeloma: Durable Responses With BCMA-Targeting Bispecific Antibodies Following Prior GPRC5D-Targeting Therapy
Titouan Cazaubiel, Cyrille Touzeau, Laure Vincent, et al.
British Journal of Haematology
|
May 7, 2022
VANDA regimen followed by blinatumomab leads to favourable outcome in patients with Philadelphia chromosome-negative B-precursor acute lymphoblastic leukaemia in first relapse
Luc Heraudet, Jean Galtier, Simon Favre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 7, 2022
In Multiple Myeloma, High-Risk Secondary Genetic Events Observed at Relapse Are Present From Diagnosis in Tiny, Undetectable Subclonal Populations
Romain Lannes, Mehmet Samur, Aurore Perrot, et al.
Clinical Hematology International
|
September 22, 2025
Improving Advanced-Line Multiple Myeloma Care: Insights and Real-World Challenges from the EMMY Study
Titouan Cazaubiel, Olivier Decaux, Bruno Royer, et al.
Blood
|
April 21, 2024
RAS/RAF landscape in monoclonal plasma cell conditions
Anais Schavgoulidze, Jill Corre, Mehmet Kemal Samur, et al.
Blood
|
February 16, 2022
Primary plasma cell leukemias displaying t(11;14) have specific genomic, transcriptional, and clinical features
Titouan Cazaubiel, Xavier Leleu, Aurore Perrot, et al.
Page
of 2